Supplementary Fig S6 from CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models
Abstract
Supplementary Fig. S6. In vivo activity of CAR27/IL-15 NK and CAR27/IL-15 T cells against BCMA-negative (TNFRSF17 KO) MM.1S cells.
Fields of Study & Subjects
CAR-T cell therapy research
Multiple Myeloma Research and Treatments
Immune Cell Function and Interaction
Publication details
- Publication date
- 4 March 2026
- Language
- EN